Etiological Factors in Urgent Gastroduodenal Ulcer

1. Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol. 1997; 92: 614-620.Search in Google Scholar

2. Dimaline R, Varro A. Attack and defence in the gastric epithelium - a delicate balance. Experimental Physiology. July 2007; Vol. 92, No. 4 pp. 591-601, ISSN 0958-0670.10.1113/expphysiol.2006.036483Search in Google Scholar

3. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008 Jul; 135(1): 41-60.10.1053/j.gastro.2008.05.030Search in Google Scholar

4. Scheiman JM. Pathogenesis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: implications for prevention and therapy. Semin Arthritis Rheum. 1992 Feb; 21(4): 201-10.10.1016/0049-0172(92)90050-NSearch in Google Scholar

5. Lanas Á, Carrera-Lasfuentes P, Arguedas Y, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2015 May; 13(5): 906-12.10.1016/j.cgh.2014.11.007Search in Google Scholar

6. Voutilainen M, Mäntynen T, Färkkilä M, et al. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol. 2001 Aug; 36(8): 817-2.10.1080/003655201750313333Search in Google Scholar

7. Scheiman JM. NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management. Dig Dis. 1994 Jul-Aug; 12(4): 210-22.10.1159/000171455Search in Google Scholar

8. Nagata N, Niikura R, Sekine K, et all. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, lowdose aspirin, and antihypertensive drugs: a case-control study. J Gastroenterol Hepatol. 2015 Feb; 3 (2): 292-8.10.1111/jgh.12805Search in Google Scholar

9. Bazzoli F, De Luca L, Graham DY. Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol. 2001 Oct; 15(5): 775-85.10.1053/bega.2001.0234Search in Google Scholar

10. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002 Jan 5; 359: 14-22.10.1016/S0140-6736(02)07273-2Search in Google Scholar

11. Zapata-Colindres JC, Zepeda-Gómez S, Montaño-Loza A, et al. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol. 2006 Apr; 20(4): 277-280.10.1155/2006/175217265990516609757Search in Google Scholar

12. Aalykke C, Lauritsen JM, Hallas J, et al. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology. 1999 Jun; 116(6): 1305-9.10.1016/S0016-5085(99)70494-4Search in Google Scholar

13. Zapata-Colindres JC., Zepeda-Gómez S, Montaño-Loza A, et all. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol. 2006 Apr; 20(4): 277-280.10.1155/2006/175217Search in Google Scholar

14. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994; 343: 769-72.10.1016/S0140-6736(94)91843-0Search in Google Scholar

15. Thorsen K, Søreide JA, Kvaløy JT. Epidemiology of perforated peptic ulcer: Age-and gender adjusted analysis of incidence and mortality. World J Gastroenterol 2013 January 21; 19(3): 347-354.10.3748/wjg.v19.i3.347355481823372356Search in Google Scholar

16. Maity P, Biswas K, Roy S, et al. Smoking and the pathogenesis of gastroduodenal ulcer--recent mechanistic update. Mol Cell Biochem. 2003 Nov; 253(1-2): 329-38.10.1023/A:1026040723669Search in Google Scholar

17. Eastwood GL. Is smoking still important in the pathogenesis of peptic ulcer disease? J Clin Gastroenterol. 1997; 25 Suppl 1: S1-7.10.1097/00004836-199700001-000039479620Search in Google Scholar

18. Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des. 2010; 16(38): 4225-36.10.2174/13816121079451907521184659Search in Google Scholar

19. McNally P. UGI Bleeding: New and Old Risk Factors. Visible Human Journal of Endoscopy. 2010 March; Volume 9, Issue 1.Search in Google Scholar

20. Chen TS, Luo JC, Chang FY. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastroduodenal ulcer diseases in Taiwan. J Gastroenterol Hepatol. 2010 May; 25(5): 919-22.10.1111/j.1440-1746.2009.06139.x20074147Search in Google Scholar

21. Gisbert JP, Legido J, García-Sanz I, et al. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2004 Feb; 36(2): 116-20.10.1016/j.dld.2003.10.01115002818Search in Google Scholar

22. Gisbert JP, Gonzalez L, de Pedro A, et al. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 2001 Jul; 36(7): 717-24.10.1080/00365520130019197811444470Search in Google Scholar

23. Matsui H, Shimokawa O, Kaneko T, et al. The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine. J Clin Biochem Nutr. Mar 2011; 48(2): 107-111.Search in Google Scholar

24. Svanes C. Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis. World J Surg. 2000 Mar; 24(3): 277-83.10.1007/s00268991004510658061Search in Google Scholar

25. Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol. 2006 Jan; 41(1): 41-6.10.1007/s00535-005-1720-y16501856Search in Google Scholar

26. Rosenstock S, Jørgensen T, Bonnevie O, et al. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003 Feb; 52(2): 186-193.10.1136/gut.52.2.186177495812524398Search in Google Scholar

27. Svanes C, Søreide JA, Skarstein A, et al. Smoking and ulcer perforation. Gut. 1997 Aug; 41(2): 177-80.10.1136/gut.41.2.17718914669301495Search in Google Scholar

28. Andersen IB, Jørgensen T, Bonnevie O, et al. Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology. 2000 Jul; 11(4): 434-9.10.1097/00001648-200007000-0001210874551Search in Google Scholar

29. Parasher G, Eastwood GL. Smoking and peptic ulcer in the Helicobacter pylori era. Eur J Gastroenterol Hepatol. 2000 Aug; 12(8): 843-53.10.1097/00042737-200012080-0000310958211Search in Google Scholar

30. Batra P, Gupta D, Narang R, et al. Spectrum of gastro intestinal perforation. Peritonitis in rural central India. J MGIMS. 2013 March; Vol 18, No (i): 44-48. Search in Google Scholar